BRD4 and leukemia: A head-to-head comparison of equimolar amounts of dBET1 and JQ-1 dosed in a model of disseminated leukaemia showed a ∼3-fold increase in antitumour activity for the bifunctional molecule over the simple BRD4 ligand.